Jackie Urban

Rare Disease Launch Leadership:

• Led the $80 million cross-functional launch of WAINUA, an orphan drug for hereditary transthyretin-mediated amyloidosis.
• Achieved 134% of the demand unit forecast in the U.S. market, establishing a benchmark for global launch success.
• Secured 40% New to Brand Share within 6 months against established competitors, exceeding all execution KPIs.

Best-in-Class Access Experience:

• Recognized for executing best-in-class, cross functional access support for hATTR-PN patients, achieving an industry leading 16-day "time to fill" and a 70% referral activation rate.

Team Development and Training Programs:

• Built AstraZeneca’s first Rare Disease Selling Team through strategic recruitment and the "NextGen Academy," fostering a diverse and purpose-driven workforce.
• Developed the "Team TTransform Training Program," utilizing Key Opinion Leaders and Patient Advocacy Groups to create a sales team of respected scientific experts.

Strategic Launch Planning:

• Crafted cross-functional launch account plans that drove a 100% increase in brand perception, doubling both share of voice and share of mind compared to pre-launch benchmarks.

Innovative Targeting and Marketing:

• Leveraged AI and digital tools, including smart suggestions, sponsored genetic testing, and geotargeted marketing, to enhance hATTR-PN patient identification and brand awareness.

Cross-Functional Team Alignment:

• Responsible for aligning the efforts of a 100-person field Sales Team, MSL Team, Account Director Team, Field Reimbursement Team, and Patient Education Managers to engage Neurologists, Cardiologists, and Hematologists/Oncologists in both Centers of Excellence and Community-Based Practices

• Circle of Excellence Winner: Achieved this distinction in 2021 and 2022 while leading a team of 8 Specialty Representatives across five metropolitan areas.
• Top Performer: Recognized as the #1 Specialty District Sales Manager in the U.S. for the adoption of Farxiga in nephrology.
• Global Centurion Winner: Presented an academic poster on Farxiga’s launch success, highlighting its impact on nephrology practices in treating chronic kidney disease and delaying dialysis.
• Cross-Functional Collaboration: Enhanced team collaboration skills, resulting in significant market access wins at Naples Community Hospital, Lee Physicians Group, Jackson Health System, and Baptist Health.
• Drove Practice Change: Improved planning and ecosystem management strategies to drive the adoption of new chronic kidney disease treatment protocols at Florida Kidney Physicians and National Kidney Partners.
• National Specialty Trainer: Led regional trainers in the field; designed and facilitated clinical workshops on Heart Failure, Type 2 Diabetes, and CKD trials, significantly boosting the team’s clinical acumen and effectiveness.

• Top Ranked DSM: Achieved Long Term Incentive Stock for three consecutive years (2017, 2018, 2019).
• District Turnaround: Elevated Lakeland District from bottom 10% nationally to TOP 11% in Circle of Excellence rank in 2017.
• National Trainer: Delivered training for first-line leaders and representatives on heart failure foundations, brand strategy, and new cardiovascular indications (Farxiga HF and Farxiga CKD).
• OmniChannel Leadership: Spearheaded national launch of Farxiga's HF indication during COVID-19 lockdown, creating and executing an OmniChannel Training program for AZ’s first fully digital launch.
• National Executive Coach: Provided coaching and development for district sales managers, including training on 4 Disciplines of Execution, Brain-Based Coaching, and Multipliers to enhance leadership capabilities across organization.
• Culture & Engagement Leader: Led the Regional Culture & Engagement team, achieving #1 Employee Engagement Pulse Scores in the East Area.

• Top Sales Performer: Achieved #1 in Region with a 12% COE Rank, awarded a long-term stock award.
• Top Revenue Contribution: Contributed highest fiscal revenue to South Florida Region (2015).
• Farxiga Launch Excellence: Achieved 193.04% of goal of launch forecasts, in a must-win market (2014).
• Regional Training Specialist: Selected as South Florida Regional Training Specialist for Diabetes Franchise, focusing on Type 2 diabetes portfolio, including Farxiga, Bydureon, and Onglyza (2016).
• Co-Lead of Regional Oncology Academy: Spearheaded workshops on Tagrisso and Lynparza, enhancing team’s understanding of oncology treatments and strategies for market expansion (2015).
• Graduated from AZ’s LEAP Program: Completed AZ's leadership development program, to prepare for first line leader position. (2015).
• Promotion to Executive Sales Specialist: Advanced to Career Ladder 4 (2014)

• Recognition: Earned AZ LTI Stock Award, Making a Difference Award for Regional Patient Adherence Campaign
• Rapid Promotion: Promoted to Career Ladder 3 into MCRO role within one year of hire.
• Market Preparation: Clinically prepared district for AstraZeneca’s entry into the T2D market
• Achievement: Winner of 2009 Fast Start Award: #1 Region for Top Crestor Regional Market Share Growth
• Training Excellence: Winner of Shining Star Training Award: #1 Representative in training class of 60 representatives.

• Recognition: Naples 2007 Teacher of the Year
• Achievement: Consistently delivered over 100% achievement on standardized test scores.
• Leadership: Led professional development initiatives for teachers on effective lesson planning and innovative instructional strategies.
• Program Development: Created inclusive programs tailored to support a diverse K-12 student population and implemented practices in special needs blended classrooms